ROYCE & ASSOCIATES LP - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 137 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.32 and the average weighting 0.9%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$18,000
-18.2%
12,344
+10.1%
0.00%
Q2 2020$22,000
+10.0%
11,209
+10.0%
0.00%
Q1 2020$20,000
-9.1%
10,189
+88.0%
0.00%
Q4 2019$22,000
-99.5%
5,420
-98.4%
0.00%
-100.0%
Q1 2016$4,070,000
+17.8%
340,589
+31.2%
0.03%
+23.8%
Q4 2015$3,455,000
-3.8%
259,589
-22.4%
0.02%
+10.5%
Q3 2015$3,591,000
+18.3%
334,374
-11.3%
0.02%
+46.2%
Q2 2015$3,035,000377,0740.01%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$34,786,00099.98%
Artal Group S.A. 57,517,978$463,019,00019.93%
MASTERS CAPITAL MANAGEMENT LLC 1,129,708$9,094,0000.30%
Rhenman & Partners Asset Management AB 170,915$1,376,0000.16%
Round Table Services, LLC 21,611$174,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$287,0000.10%
FALCON POINT CAPITAL, LLC 37,039$298,0000.10%
SABBY MANAGEMENT, LLC 318,775$2,566,0000.09%
WILLIAM HARRIS INVESTORS INC 39,495$318,0000.09%
HOWARD HUGHES MEDICAL INSTITUTE 51,520$415,0000.09%
View complete list of LEXICON PHARMACEUTICALS INC shareholders